Management of untreated advanced stage follicular lymphoma: Role of patient discernment

Management of untreated advanced stage follicular lymphoma: Role of patient discernment

Follicular lymphoma is the most common indolent non-Hodgkin lymphoma. Advanced stage disease is common at diagnosis. The timing of treatment for follicular lymphoma is best approached by considering the combination of presence or absence of symptoms along with estimation of tumor burden. Upfront tre...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Best practice & research. Clinical haematology 2018-03, Vol.31 (1), p.23-30
Hauptverfasser: Umakanthan, Jayadev Manikkam, Lunning, Mathew A.
Format: Artikel
Sprache:eng
Schlagworte:
Advanced stage
Follicular Lymphoma
Treatment
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 30
container_issue 1
container_start_page 23
container_title Best practice & research. Clinical haematology
container_volume 31
creator Umakanthan, Jayadev Manikkam
Lunning, Mathew A.
description Follicular lymphoma is the most common indolent non-Hodgkin lymphoma. Advanced stage disease is common at diagnosis. The timing of treatment for follicular lymphoma is best approached by considering the combination of presence or absence of symptoms along with estimation of tumor burden. Upfront treatment strategies should take into initial presentation variables, pace of disease progression and goals of care after discussion with the patient. Treatment approaches remain diverse and patient discernment is paramount.
doi_str_mv 10.1016/j.beha.2017.10.004
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2003045643</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1521692617300555</els_id><sourcerecordid>2003045643</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-a023961046ae23d50b0ceb1dc008ee2f392c79db6a599fd74b7ebf88259f43cd3</originalsourceid><addsrcrecordid>eNp9kE1LAzEQhoMotlb_gAfZo5dd87XZRrxI8QsqgigeQzaZtVv2oya7hf57E6oePc0w874vMw9C5wRnBBNxtc5KWOmMYlKEQYYxP0BTkjOaEkn5YewpSYWkYoJOvF9jzJik7BhNqOQ5FYJN0cez7vQntNANSV8lYzc40APYRNut7kxo_BD2SdU3TW3GRruk2bWbVd_q6-S1byC6NnqoY4CtvQHXxbBTdFTpxsPZT52h9_u7t8Vjunx5eFrcLlPDcjGkGlMmBcFcaKDM5rjEBkpiDcZzAFqFe00hbSl0LmVlC14WUFbzOc1lxZmxbIYu97kb13-N4AfVxiOaRnfQj17R8DTmueAsSOlealzvvYNKbVzdardTBKsIVK1VBKoi0DgLQIPp4id_LFuwf5ZfgkFwsxdA-HJbg1PeBBiBXO3ADMr29X_530Nqh6Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2003045643</pqid></control><display><type>article</type><title>Management of untreated advanced stage follicular lymphoma: Role of patient discernment</title><source>Elsevier ScienceDirect Journals</source><creator>Umakanthan, Jayadev Manikkam ; Lunning, Mathew A.</creator><creatorcontrib>Umakanthan, Jayadev Manikkam ; Lunning, Mathew A.</creatorcontrib><description>Follicular lymphoma is the most common indolent non-Hodgkin lymphoma. Advanced stage disease is common at diagnosis. The timing of treatment for follicular lymphoma is best approached by considering the combination of presence or absence of symptoms along with estimation of tumor burden. Upfront treatment strategies should take into initial presentation variables, pace of disease progression and goals of care after discussion with the patient. Treatment approaches remain diverse and patient discernment is paramount.</description><identifier>ISSN: 1521-6926</identifier><identifier>EISSN: 1532-1924</identifier><identifier>DOI: 10.1016/j.beha.2017.10.004</identifier><identifier>PMID: 29452663</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Advanced stage ; Follicular Lymphoma ; Treatment</subject><ispartof>Best practice &amp; research. Clinical haematology, 2018-03, Vol.31 (1), p.23-30</ispartof><rights>2017 Elsevier Ltd</rights><rights>Copyright © 2017 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-a023961046ae23d50b0ceb1dc008ee2f392c79db6a599fd74b7ebf88259f43cd3</citedby><cites>FETCH-LOGICAL-c356t-a023961046ae23d50b0ceb1dc008ee2f392c79db6a599fd74b7ebf88259f43cd3</cites><orcidid>0000-0002-8746-4240</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1521692617300555$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29452663$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Umakanthan, Jayadev Manikkam</creatorcontrib><creatorcontrib>Lunning, Mathew A.</creatorcontrib><title>Management of untreated advanced stage follicular lymphoma: Role of patient discernment</title><title>Best practice &amp; research. Clinical haematology</title><addtitle>Best Pract Res Clin Haematol</addtitle><description>Follicular lymphoma is the most common indolent non-Hodgkin lymphoma. Advanced stage disease is common at diagnosis. The timing of treatment for follicular lymphoma is best approached by considering the combination of presence or absence of symptoms along with estimation of tumor burden. Upfront treatment strategies should take into initial presentation variables, pace of disease progression and goals of care after discussion with the patient. Treatment approaches remain diverse and patient discernment is paramount.</description><subject>Advanced stage</subject><subject>Follicular Lymphoma</subject><subject>Treatment</subject><issn>1521-6926</issn><issn>1532-1924</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kE1LAzEQhoMotlb_gAfZo5dd87XZRrxI8QsqgigeQzaZtVv2oya7hf57E6oePc0w874vMw9C5wRnBBNxtc5KWOmMYlKEQYYxP0BTkjOaEkn5YewpSYWkYoJOvF9jzJik7BhNqOQ5FYJN0cez7vQntNANSV8lYzc40APYRNut7kxo_BD2SdU3TW3GRruk2bWbVd_q6-S1byC6NnqoY4CtvQHXxbBTdFTpxsPZT52h9_u7t8Vjunx5eFrcLlPDcjGkGlMmBcFcaKDM5rjEBkpiDcZzAFqFe00hbSl0LmVlC14WUFbzOc1lxZmxbIYu97kb13-N4AfVxiOaRnfQj17R8DTmueAsSOlealzvvYNKbVzdardTBKsIVK1VBKoi0DgLQIPp4id_LFuwf5ZfgkFwsxdA-HJbg1PeBBiBXO3ADMr29X_530Nqh6Q</recordid><startdate>201803</startdate><enddate>201803</enddate><creator>Umakanthan, Jayadev Manikkam</creator><creator>Lunning, Mathew A.</creator><general>Elsevier Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-8746-4240</orcidid></search><sort><creationdate>201803</creationdate><title>Management of untreated advanced stage follicular lymphoma: Role of patient discernment</title><author>Umakanthan, Jayadev Manikkam ; Lunning, Mathew A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-a023961046ae23d50b0ceb1dc008ee2f392c79db6a599fd74b7ebf88259f43cd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Advanced stage</topic><topic>Follicular Lymphoma</topic><topic>Treatment</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Umakanthan, Jayadev Manikkam</creatorcontrib><creatorcontrib>Lunning, Mathew A.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Best practice &amp; research. Clinical haematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Umakanthan, Jayadev Manikkam</au><au>Lunning, Mathew A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Management of untreated advanced stage follicular lymphoma: Role of patient discernment</atitle><jtitle>Best practice &amp; research. Clinical haematology</jtitle><addtitle>Best Pract Res Clin Haematol</addtitle><date>2018-03</date><risdate>2018</risdate><volume>31</volume><issue>1</issue><spage>23</spage><epage>30</epage><pages>23-30</pages><issn>1521-6926</issn><eissn>1532-1924</eissn><abstract>Follicular lymphoma is the most common indolent non-Hodgkin lymphoma. Advanced stage disease is common at diagnosis. The timing of treatment for follicular lymphoma is best approached by considering the combination of presence or absence of symptoms along with estimation of tumor burden. Upfront treatment strategies should take into initial presentation variables, pace of disease progression and goals of care after discussion with the patient. Treatment approaches remain diverse and patient discernment is paramount.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>29452663</pmid><doi>10.1016/j.beha.2017.10.004</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-8746-4240</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1521-6926
ispartof Best practice & research. Clinical haematology, 2018-03, Vol.31 (1), p.23-30
issn 1521-6926
1532-1924
language eng
recordid cdi_proquest_miscellaneous_2003045643
source Elsevier ScienceDirect Journals
subjects Advanced stage
Follicular Lymphoma
Treatment
title Management of untreated advanced stage follicular lymphoma: Role of patient discernment
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T04%3A06%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Management%20of%20untreated%20advanced%20stage%20follicular%20lymphoma:%20Role%20of%20patient%20discernment&rft.jtitle=Best%20practice%20&%20research.%20Clinical%20haematology&rft.au=Umakanthan,%20Jayadev%20Manikkam&rft.date=2018-03&rft.volume=31&rft.issue=1&rft.spage=23&rft.epage=30&rft.pages=23-30&rft.issn=1521-6926&rft.eissn=1532-1924&rft_id=info:doi/10.1016/j.beha.2017.10.004&rft_dat=%3Cproquest_cross%3E2003045643%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2003045643&rft_id=info:pmid/29452663&rft_els_id=S1521692617300555&rfr_iscdi=true